A drug belonging to the sulfonamide group of antibacterial drugs. It is used in the treatment of ulcerative colitis and Crohn’s disease, and also of severe rheumatoid arthritis.
Sulfasalazine (Alzulfidine) is a sulfa drug used to treat and prevent inflammatory bowel disease, such as ulcerative colitis or Crohn disease. It works inside the bowel to reduce inflammation and other symptoms of the disease. Sulfasalazine is also used to treat rheumatoid arthritis for people who experience side effects from other arthritis drugs.
A drug of the sulfonamide group, used in the treatment of ulcerative colitis. It is given by mouth or in the form of suppositories. The most common side-effects are nausea, loss of appetite, and raised temperature.
A chemical combination of sulphapyridine and 5-aminosalycilic acid. It is used to treat ulcerative colitis (valuable as oral therapy for mild symptomatic disease; also available as suppositories for rectal disease) and rheumatoid arthritis. The salicylate part is now available alone in drugs such as mesalazine and olsalazine.
An antirheumatic drug that modifies the course of disease and is additionally employed to alleviate intestinal inflammation in conditions like Crohn’s disease and ulcerative colitis. Notable adverse effects encompass aplastic anemia and a decrease in white blood cells and platelets; periodic blood counts are typically conducted. Sulfasalazine can also trigger other unfavorable reactions such as nausea, headache, fever, and loss of appetite.